Meanwhile, TGF-β can promote the expression of miR-208 in HCC cells, which attenuates the inhibitory effect on IFITM1 activity by targeting ARID2, and ultimately promote tumor progression [163] (Fig. 7A). Here, TGFB1 is linked to neoplasm.